Clinical trial

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

NCT00314405 · University Hospital, Strasbourg, France, Other · Completed

Key facts

NCT number NCT00314405
Title Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope
Official title Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.
Lead sponsor University Hospital, Strasbourg, France, Other
Status Completed
Study type Interventional
Conditions Infiltrative Breast Cancer
Intervention type Drug, Procedure
Interventions Methylene blue (1%), Rhenium sulfure, Surgical procedure, Anatomo-pathologic procedure
Enrollment 100
Start date Apr 1, 2006
Primary completion Apr 1, 2007
First posted Apr 13, 2006
Last update posted Dec 22, 2025
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies